Prenatal cannabis exposure associated with small increases in autism and ADHD risk
Meta-analysis found gestational cannabis exposure associated with a 30% increased risk of autism spectrum disorder and a 13% increase in ADHD, while a large cohort study found cannabis use disorder before or during pregnancy linked to 3x higher ASD risk.
Quick Facts
What This Study Found
Meta-analysis of 13 studies found gestational cannabis exposure associated with ASD (RR 1.30) and ADHD (RR 1.13, possibly supported by publication bias). A separate cohort study (n=222,534) found peri-pregnancy cannabis use disorder associated with ASD (RRs 3.02-3.21), with larger effects in nonsmokers (RRs 4.55-4.83) than smokers (RRs 1.74-1.87).
Key Numbers
ASD meta-analysis RR: 1.30 (4 studies, N=178,565). ADHD meta-analysis RR: 1.13 (10 studies, N=203,783). Cohort study CUD and ASD: RR 3.02-3.21 (n=222,534). Nonsmokers: RR 4.55-4.83. Smokers: RR 1.74-1.87.
How They Did This
Review of a meta-analysis (4 ASD studies, pooled N=178,565; 10 ADHD studies, pooled N=203,783) plus a large retrospective cohort study (n=222,534) examining associations between prenatal cannabis exposure and neurodevelopmental outcomes.
Why This Research Matters
Up to 10% of women may use cannabis during pregnancy, and constituents cross the placental barrier to act on cannabinoid receptors in the developing fetal brain. Understanding neurodevelopmental risks is essential for informed decision-making.
The Bigger Picture
The field connecting prenatal cannabis to neurodevelopmental outcomes is still nascent, with relatively small numbers of cannabis-exposed pregnancies studied globally. The difference between the meta-analysis (RR 1.30) and cohort study (RR ~3.0) may reflect differences in exposure measurement, with CUD representing heavier use.
What This Study Doesn't Tell Us
The ADHD finding may be influenced by publication bias. Cannot separate cannabis effects from genetic, environmental, or behavioral confounders. Small total number of exposed pregnancies worldwide. CUD is a proxy for heavy use, not any use.
Questions This Raises
- ?Why was the ASD risk higher in nonsmokers than smokers?
- ?Is the association driven by heavy use (CUD) specifically, or does any prenatal exposure carry risk?
Trust & Context
- Key Stat:
- RR 1.30 for ASD (meta-analysis)
- Evidence Grade:
- Meta-analysis of observational studies plus large cohort, but observational design cannot establish causation and confounding remains possible.
- Study Age:
- 2024 review of a meta-analysis and large cohort study
- Original Title:
- Maternal Cannabis Use in Pregnancy and Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder in Offspring.
- Published In:
- The Journal of clinical psychiatry, 86(1) (2024)
- Authors:
- Andrade, Chittaranjan(4)
- Database ID:
- RTHC-05080
Evidence Hierarchy
Frequently Asked Questions
Does prenatal cannabis cause autism?
The studies found associations, not proven causation. Genetic, environmental, or behavioral factors shared by cannabis-using mothers could partly explain the link. However, cannabis constituents do cross the placenta and can affect fetal brain development.
Why was the risk higher for nonsmokers?
The authors speculated this could be because tobacco smoking introduces competing toxins that may obscure or modify the cannabis-specific effect, or because nonsmoking cannabis users may use different forms or amounts.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-05080APA
Andrade, Chittaranjan. (2024). Maternal Cannabis Use in Pregnancy and Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder in Offspring.. The Journal of clinical psychiatry, 86(1). https://doi.org/10.4088/JCP.24f15717
MLA
Andrade, Chittaranjan. "Maternal Cannabis Use in Pregnancy and Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder in Offspring.." The Journal of clinical psychiatry, 2024. https://doi.org/10.4088/JCP.24f15717
RethinkTHC
RethinkTHC Research Database. "Maternal Cannabis Use in Pregnancy and Autism Spectrum Disor..." RTHC-05080. Retrieved from https://rethinkthc.com/research/andrade-2024-maternal-cannabis-use-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.